Pharmaceutical manufacturer for Choline alfoscerate

Our proprietary products (APIs) cater to the general pharmaceutical sector. We consistently deliver high-quality products and services, utilizing some of the most challenging chemical technologies in the world responsibly and continuously

Chemi S.p.A. is a prominent Italian pharmaceutical company specializing in the research, development, and manufacturing of high-quality generic drugs and active pharmaceutical ingredients (APIs). With over 50 years of experience, Chemi S.p.A. is renowned for its expertise in complex chemistry and its commitment to innovation. The company operates in various therapeutic areas, including oncology, cardiovascular diseases, and central nervous system disorders, providing advanced healthcare solutions to patients globally.

Kukjeon Pharmaceutical has been actively contributing to the advancement of South Korea's pharmaceutical industry by supplying active pharmaceutical ingredients (API) developed through 50 years of professional capacity building. Currently, we provide API to more than 200 pharmaceutical and electronics companies domestically and internationally. We are a comprehensive chemical solution provider offering a wide range of chemical-based products and services, supported by an organizational system and the capability to engage in research and development as well as foundational businesses.

Our aim is to become a prominent company in the API and key intermediates industry. Established in 1994, our company is a certified GMP enterprise, specializing in the manufacturing of APIs (Active Pharmaceutical Ingredients), key intermediates of APIs, and fine chemicals. We pride ourselves on delivering high-quality products (APIs and key intermediates) that are meticulously prepared under stringent quality control and exceptional process management. Furthermore, we are a dynamic venture company striving to emerge as a global leader in the generic API industry. Through continuous research and development, we are enhancing our research capabilities and proprietary technology.

Established in the year 2000 as Dongwoo Shintech Co., Ltd., INIST ST has emerged as a pioneer in the advancement of pharmaceutical raw materials and the technology for synthesizing raw materials. Guided by the principles of transformation, innovation, and a passion for life, INIST ST has been engaged in the exploration and production of high-caliber generic raw materials and enhanced drugs through salt modification, commencing with the development of treatments for cerebrovascular diseases and distributing them both nationally and globally. Backed by unwavering trust and expertise, it is utilized as a contrast agent for heart disease and serves as the basis for numerous original active ingredients.

Korea Biochem Pharm. Inc. is a pharmaceutical company founded in 2010. We distribute approximately 30 different APIs and finished products domestically and also export to Europe. Korea Biochem aims to achieve the status of a globally recognized healthcare company, striving for the betterment of global health culture and the establishment of a welfare society through the highest level of R&D investment and innovative technical skills while upholding the value of life.

Since the establishment of our company SAMHWA in 1991, we have been committed to the principles of faithfulness, harmony, and trust, driving continuous improvement in technical development and human resources. With extensive experience and expertise, we specialize in fabricating major items such as piping, coils, headers, and pressure parts for boilers. Our top priorities are environmental sustainability and safety, as reflected in our impeccable safety record at the workshop. We are dedicated to constantly evolving and enhancing our business management to foster innovation and meet new challenges. SAMHWA isn't just a manufacturer and seller of products.

Warrant Pharmaceutical Group is a modern publicly traded company established in 2001, dedicated to the pharmaceutical sector. With 4 manufacturing facilities and 1 research and development center, furnished with cutting-edge equipment and machinery, all situated in an eco-friendly industrial park to promote our sustainable growth. Involved in the production and distribution of APIs and Intermediates, Solid Dosage Formulations, herb DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News, GMP Hunan Warrant Chiral Pharmaceutical

Established in 2001, Hunan Jiudian Pharmaceutical Co., Ltd. is a contemporary GMP pharmaceutical and publicly traded company specializing in finalized products, active pharmaceutical ingredients (APIs), excipients, traditional Chinese medicine, and nutritional supplements. Boasting 2 facilities, 400 researchers, and a total of 1,900 employees, the company's primary products are all independently researched by its own team, encompassing analgesic drugs, cardio-cerebrovascular treatments, anti-infection solutions, digestive and urinary system aids, as well as respiratory and anti-allergy products. Additionally, Hunan Jiudian Hongyang Pharmaceutical Co., Ltd. functions as a wholly-owned subsidiary of Jiudian, focusing on the production of APIs and excipients.

Ever since its establishment in 2000, Pharmacostech has played a prominent role in the fine chemical industry. The company has cultivated fundamental technologies, optimized manufacturing processes, and harnessed new discoveries from both internal and external laboratories. This includes the synthesis of novel chemicals and the development of environmentally-friendly processes, which have been successfully commercialized. In 2005, they commissioned a state-of-the-art GMP factory in Hwaseong, Gyeonggido, building upon their advanced technology. Today, Pharmacostech is embarking on its next challenge as a leading API producer.

Hwail Pharm is a South Korean pharmaceutical company established in 1980. They operate in two main areas: Pharmaceutical Raw Materials: Hwail Pharm manufactures and distributes various ingredients used in the production of medications, including antitussives, expectorants, and anti-inflammatories. Finished Formulations: They also produce and sell finished pharmaceutical products, such as injection solutions like ceftazidime and cefoperazone. The company has its headquarters in Hwaseong, South Korea, and is a significant player in the South Korean pharmaceutical market. They prioritize quality and adhere to international standards in their manufacturing and distribution processes. Additionally, they offer food ingredients beyond pharmaceuticals.

SK pharmteco specializes in the production and manufacture of APIs, Advanced Intermediates, Registered Starting Materials and Key Building Blocks for commercial and clinical purposes. Our services encompass process R&D, development of analytical methods and stability, scale-up and optimization, validation, and commercial production of small molecules, along with extensive work on Adeno-Associated Virus (AAV) and Lentiviral vectors.

The pharmaceutical company Dasan Pharmaceutical Co., Ltd. specializes in the development, production, and promotion of technically enhanced APIs, semi-formulation products, and custom formulation and manufacturing for insoluble molecules and sustained release pellets. They are conducting creative DDS research to meet the growing demand for improved generic development, utilizing high-tech biotechnology and Drug Delivery System (DDS). This research is poised to shape the future of the pharmaceutical industry and formulation technology in the 21st century. Shanghai Desano Pharmaceuticals Co., Ltd. (Desano), established in 1996 and headquartered in Shanghai Zhangjiang Hi-tech park, is committed to the research and development, manufacturing, sales, and marketing of high-quality pharmaceutical drugs, with a focus on addressing global public health diseases such as HIV and malaria.

BMI Korea is a widely recognized producer of bio-pharmaceutical formulations and medical equipment in South Korea. Drawing on innovative expertise, knowledge, and technologies, the company has been actively involved in the development and production of various pharmaceutical products for over ten years, aiming to promote a healthy life for all individuals by continuously striving for growth.

Korea Fine Chemical Co., LTD., an organization at the forefront of shaping perspectives. We are committed to advancing technology with an innovative and daring approach, aiming to become a valued global entity for our clientele.

Obtained in July 2015 and functioning as a fully owned subsidiary of Porton Fine Chemicals, Jiangxi Dongbang Pharmaceutical Co., Ltd.?“Dongbang Pharmaceuticals”) was founded in December 2007. Positioned in Jiangxi Province [75 kilometers from Changbei Airport], Dongbang Pharmaceuticals is an essential component of Porton’s strategically diverse manufacturing network, and delivers effective back-integration solutions to our international clients by proficiently manufacturing commercial-scale starting materials for conversion to RSMs or GMP intermediates at other Porton facilities.

HSBio Co., Ltd. was founded in February 2015 with the aim of becoming a well-regarded company at the forefront of the domestic and international API sector. By prioritizing quality, continuous research and development, enlisting top-notch researchers, and enhancing professional skills, we are dedicated to advancing specialized APIs and promoting public healthcare. Furthermore, we are committed to always leaving a positive impression on our customers and maintaining steadfast collaboration.

Established in 2005, IT-CHEM CO., LTD. in South Korea has developed extensive experience in supplying and trading Opc, ink, oled, and other related products. This supplier, located in Cheongwon-gun, Chungbuk, is a prominent vendor of the mentioned products. Purchase Opc, ink, and oled in large quantities from us for top-notch product quality and service.